This site displays a prototype of a “Web 2.0” version of the daily Federal Register. It is not an official legal edition of the Federal Register, and does not replace the official print version or the official electronic version on GPO’s govinfo.gov.
The documents posted on this site are XML renditions of published Federal Register documents. Each document posted on the site includes a link to the corresponding official PDF file on govinfo.gov. This prototype edition of the daily Federal Register on FederalRegister.gov will remain an unofficial informational resource until the Administrative Committee of the Federal Register (ACFR) issues a regulation granting it official legal status. For complete information about, and access to, our official publications and services, go to About the Federal Register on NARA's archives.gov.
The OFR/GPO partnership is committed to presenting accurate and reliable regulatory information on FederalRegister.gov with the objective of establishing the XML-based Federal Register as an ACFR-sanctioned publication in the future. While every effort has been made to ensure that the material on FederalRegister.gov is accurately displayed, consistent with the official SGML-based PDF version on govinfo.gov, those relying on it for legal research should verify their results against an official edition of the Federal Register. Until the ACFR grants it official status, the XML rendition of the daily Federal Register on FederalRegister.gov does not provide legal notice to the public or judicial notice to the courts.
Food and Drug Administration, HHS.
Announcement of meeting; request for comments; correction.
The Food and Drug Administration (FDA) is correcting a document that appeared in the Federal Register of August 14, 2012 (77 FR 48491). The document announced a meeting entitled “Regulatory New Drug Review: Solutions for Study Data Exchange Standards.” The document was published with an incorrect email address. This document corrects that error.
Ron Fitzmartin, Office of Planning & Informatics, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 51, Rm. 1160, Silver Spring, MD 20993-0002, 301-796-5333, FAX: 301-847-8443, email: CDERDataStandards@fda.hhs.gov.
In FR Doc. 2012-19748, appearing on page 48491 in the Federal Register of August 14, 2012, the following corrections are made:
1. On page 48491, in the first column, in the FOR FURTHER INFORMATION CONTACT section, the email address “ CDERDataStandards@hhs.fda.gov ” is corrected to read “ CDERDataStandards@fda.hhs.gov.”
2. On page 48491, in the second column, in the SUPPLEMENTARY INFORMATION section, under “ Registration, ” the email address “ CDERDataStandards@hhs.fda.gov ” is corrected to read “ CDERDataStandards@fda.hhs.gov.”
Dated: September 11, 2012.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2012-22793 Filed 9-14-12; 8:45 am]
BILLING CODE 4160-01-P